Bedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
Bedford Pharmacy is recalling P-P (COBAL) 30-0.5/mL injections because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of infection associated with a lack of sterility assurance in an injectable product.
Plain-English summary
Bedford Pharmacy is recalling P-P (COBAL) 30-0.5/mL injections due to a lack of assurance of sterility. The recalled product consists of 1 vial per unit. The specific lot number is 08262015@9, and the expiration date is 10/10/2015.
The recalled injections were distributed in New Hampshire and Massachusetts. The recall was initiated by Bedford Pharmacy, located at 209 Route 101, Bedford, NH 03110.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- P-P (COBAL)30-0.5/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
- Manufacturer
- Bedford Pharmacy
- Category
- Drug — Injection
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 08262015@9
- Exp 10/10/2015
Distribution
Part of a larger recall action
This product is one of 13 recalled by Bedford Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Bedford Pharmacy
See all →- HighBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Propofol Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharm D Solutions Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereVitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereDowning Labs Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereB&B Pharmacy Recalls PGE 30mcg/ml Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-18
- SevereMethylcobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24